Inthervaxsp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2018-08-29
Share capital
5,000.00 PLN
Registered address
ul. Zambrowska 36, 61-051 Poznań, Poland

Financials

This entity has not filed any financial documents with the Financial Document Repository (RDF).

Authorized Representatives

Andrzej Adam Mackiewicz – President of the Management Board
Jacek Mackiewicz – Management Board Member

Manner of representation

Each member of the management board has the right to represent the company independently.

Ownership

OwnerSharesShare valueStake
10$135.0610%
Andrzej Adam Mackiewiczage 73
80$1,080.5080%
Jacek Mackiewiczage 47
10$135.0610%

Andrzej Adam Mackiewicz and Jacek Mackiewicz hold a combined 90% – the ownership structure indicates family control.

Beneficial owners

No beneficial owners recorded for the company Inthervax.

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
Jul 13, 2026Dissolution without liquidation opened

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
GenxoneS.A.
Polbiotech Laboratoriumsp. z o.o.
Explorna Therapeuticssp. z o.o.
Relvosp. z o.o.
Microblicsp. z o.o.
Xenstatssp. z o.o.
Fungotechsp. z o.o.
Ncage TherapeuticsS.A.
Dystrogen TherapeuticsS.A.
MIMO BiotechP.S.A.

FAQ

Last updated: 2026-04-08